Recent Quotes (30 days)

You have no recent quotes
chg | %

Roche Holding Ltd. (ADR)  

(Public, OTCMKTS:RHHBY)   Watch this stock  
Find more results for PINK:RHHBY
36.51
-0.05 (-0.14%)
After Hours: 36.47 -0.04 (-0.11%)
Aug 29, 4:00PM EDT  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 36.29 - 36.54
52 week 30.91 - 38.71
Open 36.37
Vol / Avg. 591,209.00/584,837.00
Mkt cap 250.39B
P/E 21.43
Div/yield 1.11/3.04
EPS 1.70
Shares 689.39M
Beta 0.63
Inst. own 14%
Nov 20, 2014
Roche Holding AG at Jefferies Global Heatlhcare Conference - London Add to calendar
Nov 18, 2014
Roche Holding AG at Stifel Healthcare Conference Add to calendar
Nov 12, 2014
Roche Holding AG at UBS European Conference Add to calendar
Oct 16, 2014
Q3 2014 Roche Holding AG Earnings Release Add to calendar
Oct 16, 2014
Q3 2014 Roche Holding AG Earnings Conference Call Add to calendar
Sep 29, 2014
Roche Holding AG Investor Science Conference Call from ESMO 2014 - 4:00AM EDT - Add to calendar
Sep 18, 2014
Roche Holding AG at Bernstein Strategic Decisions Conference Add to calendar
Sep 17, 2014
Roche Holding AG at �Bank of America Merrill Lynch Global Healthcare Conference Add to calendar
Sep 10, 2014
Roche Holding AG at Societe Generale Income Conference Add to calendar
Sep 3, 2014
Roche Holding AG at Goldman Sachs European Medtech and Healthcare Services Conference Add to calendar
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 24.55% 24.31%
Operating margin 35.48% 34.99%
EBITD margin - 41.93%
Return on average assets 18.13% 17.91%
Return on average equity 60.12% 66.04%
Employees 81,769 -
CDP Score - 96 B

Address

Grenzacherstrasse 124
Basel, 4070
Switzerland
+41-9-732354295 (Phone)

Website links

External links

Description

Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. Pharmaceuticals are divided into two sub-divisions: Roche Pharmaceuticals and Chugai. It operates in the United States, Western Europe, Japan, CEMAI (Central and Eastern Europe, Middle East, Africa, Central Asia, Indian Subcontinent), Latin America, Asia-Pacific and Other regions. Diagnostics include five business areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan.

Officers and directors

Severin Schwan Chairman of the Corporate Executive Committee, Chief Executive Officer, Director
Age: 47
Alan Hippe Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
Age: 47
Stephan Feldhaus Member of the Enlarged Corporate Executive Committee, Head Group Communications
Age: 52
Sophie Kornowski-Bonnet Member of the Enlarged Corporate Executive Committee, Head of Roche Partnering
Age: 50
Osamu Nagayama Member of the Enlarged Corporate Executive Committee, President and Chief Executive Officer of Chugai
Age: 66
John C. Reed M.D., Ph.D. Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
Age: 56
Richard H. Scheller Ph.D. Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
Age: 61
Urs Jaisli Chief Compliance Officer
Age: 58
Gottlieb A. Keller Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors
Age: 60
Silvia Ayyoubi Member of the Corporate Executive Committee, Head of Group Human Resources
Age: 61